Molecular imaging refers to the use of non-invasive imaging techniques to detect signals that originate from molecules, often in the form of an injected tracer, and observe their interaction with a specific cellular target in vivo. Differences in the underlying physical principles of these measurement techniques determine the sensitivity, specificity and length of possible observation of the signal, characteristics that have to be traded off according to the biological question under study. Here, we describe the specific characteristics of single photon emission computed tomography (SPECT) relative to other molecular imaging technologies. SPECT is based on the tracer principle and external radiation detection. It is capable of measuring the biodistribution of minute (<10(-10) molar) concentrations of radio-labelled biomolecules in vivo with sub-millimetre resolution and quantifying the molecular kinetic processes in which they participate. Like some other imaging techniques, SPECT was originally developed for human use and was subsequently adapted for imaging small laboratory animals at high spatial resolution for basic and translational research. Its unique capabilities include (i) the ability to image endogenous ligands such as peptides and antibodies due to the relative ease of labelling these molecules with technetium or iodine, (ii) the ability to measure relatively slow kinetic processes (compared with positron emission tomography, for example) due to the long half-life of the commonly used isotopes and (iii) the ability to probe two or more molecular pathways simultaneously by detecting isotopes with different emission energies. In this paper, we review the technology developments and design tradeoffs that led to the current state-of-the-art in SPECT small animal scanning and describe the position SPECT occupies within the matrix of molecular imaging technologies.

In a previous simulation study, we demonstrated the feasibility of using coded apertures together with pixelated detectors tors for small animal SPECT. In this paper; we further explore the potential of this approach with a prototype detector and simulated multipinhole apertures. We also investigated the effect of multiplexing due to overlapped projections on convergence properties, image signal-to-noise ratio (SNR) and spatial resolution. The detector comprises a 48/spl times/44 array of NaI(Tl) crystals, each 1 mm/spl times/1 mm/spl times/5 mm on a 1.25-mm pitch. The crystal array is directly coupled to a Hamamatsu R3941 8 cm position sensitive photomultiplier tube. Multipinhole apertures were simulated by performing repeated SPECT acquisitions of the same object with a single tungsten pinhole translated to different positions in the aperture plane. Image reconstruction is based on a three-dimensional ray driven projector which is an extension of a method described for single pinhole SPECT with a displaced center of rotation. Image estimates are updated using the maximum likelihood expectation maximization (ML-EM) algorithm. The effect of multiplexing was to slow convergence and reduce the achievable SNR by approximately 15% compared with nonmultiplexed data (but the result may be achieved in a fraction of the time). The reconstructed resolution obtained with a resolution phantom was 1.5-mm full width at half maximum and there was no appreciable difference between the resolution of multiplexed and nonmultiplexed data. These results encourage us to develop a prototype coded aperture system for high sensitivity, high resolution small animal SPECT.

A reasonable level of agreement (P < .01) between actual clinical reporting and test set conditions in screening mammography can be achieved when describing group performance if prior images are pr... PurposeTo establish the extent to which test set reading can represent actual clinical reporting in screening mammography.Materials and MethodsInstitutional ethics approval was granted, and informe...

Breast cancer affects approximately half a million women globally every year¹ x 1 WHO international agency for research on cancer. World cancer report. (Available at); 2003 http://www.iarc.fr/en/publications/pdfs-online/wcr/2003/index.php. ([accessed 10.06.11]) Google Scholar See all References and it is the leading cause of mortality amongst females in Australia.² x 2 Australian institute of health and welfare (AIHW), Cancer Australia & Australasian association of cancer registries 2008. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. (Cancer Series no. 42. Cat. no. CAN 38)AIHW, Canberra; 2008 Google Scholar See all References Population screening mammography is critical in detecting early breast cancer and has been found to reduce the mortality rate by 26% for women aged 50–74 years.³ x 3 Kerlikowske, K., Grady, D., Rubin, S.M. et al. Efficacy of screening mammography—a meta-analysis. J Am Med Assoc. 1995; 273: 149–154 Crossref | Scopus (893) | Google Scholar See all References In Australia, women aged 50–69 years are actively targeted to participate in the BreastScreen Australia programme.⁴ x 4 BreastScreen Australia program. About the program—background. (Available at)http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/breastscreen-about. ([accessed 24.04.09]) Google Scholar See all References Successful screening mammography relies on the accurate interpretation of mammograms by screen readers, predominantly but not exclusively, radiologists; however, missed cancers and false-positive recall rates reported amongst radiologists are problems that compromise the success of breast screening programmes.⁵ x 5 Beam, C.A., Layde, P.M., and Sullivan, D.C. Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample. Arch Intern Med. 1996; 156: 209–213 Crossref | PubMed | Google Scholar See all References ^{, 6} x 6 Elmore, J.G., Wells, C.K., Lee, C.H. et al. Variability in radiologists' interpretations of mammograms. New Engl J Med. 1994; 331: 1493–1499 Crossref | PubMed | Scopus (448) | Google Scholar See all References ^{, 7} x 7 Kessler, L.G., Andersen, M.R., and Etzioni, R. Much ado about mammography variability. J Natl Cancer Inst. 2002; 94: 1346–1347 Crossref | PubMed | Google Scholar See all References ^{, 8} x 8 Elmore, J.G., Miglioretti, D.L., Reisch, L.M. et al. Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst. 2002; 94: 1373–1380 Crossref | PubMed | Google Scholar See all References In the USA, it was found that 10–30% of breast cancer goes unreported during screening mammography.⁹ x 9 Bird, R.E., Wallace, T.W., and Yankaskas, B.C. Analysis of cancers missed at screening mammography. Radiology. 1992; 184: 613–617 PubMed | Google Scholar See all References An evaluation performed by BreastScreen Australia reported a sensitivity of approximately 70% over a period of 2 years in detecting breast cancers amongst all women attending the breast screening program, and almost 50% of cancers were missed in the 40–49-year-old group.¹⁰ x 10 BreastScreen Australia evaluation. Evaluation final report. (Available at)http://www.health.gov.au/internet/screening/publishing.nsf/Content/8463830B90E5BDF5CA25762A000193C6/$File/Breastscreen%20Aust_REPORT.pdf. ([accessed 11.11.11]) Google Scholar See all References